Interaction of Caffeine and Hydration on Voice

NCT01435837 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2013-06-11

No results posted yet for this study

Summary

The purpose of the study, Effects of Interaction of Caffeine and Hydration on Voice Performance, is to gather information about the effects of caffeine and hydration upon voice performance. The research question involves whether systemic hydration may reduce degradation on voice performance caused by caffeine ingestion. It is hypothesized that the hydration conditions will result in a less degraded vocal performance as compared with the nonhydration condition.The investigation involves abstention from any caffeine ingestion for 24 hours - from 8pm the day before testing to 8am the morning of testing. In addition, preparation for participation involves abstaining from ingesting any foods and liquids for 12 hours - from 8pm to 8am of the following morning. Each test will take about 10 minutes.

Conditions

  • Voice Disorders

Interventions

DRUG

C2 (200mg of caffeine; 1/2 L of water)

200mg of caffeine (tablet); 1/2 of water

DRUG

C3(200mg of caffeine; 1 L of water)

Ingestion of 200 mg of caffeine and 1 Liter of water after between pretest and posttest.

DRUG

C1 (200mg of caffeine, no water)

Ingestion of 200mg of caffeine (tablet); no water ingestion.

DRUG

Placebo (no caffeine, no water).

No ingestion of caffeine; no ingestion of water between pretest and posttest.

Sponsors & Collaborators

  • Southern Illinois University Carbondale

    lead OTHER

Principal Investigators

  • Maria Claudia Franca, Ph.D. · Southern Illinois University Carbondale

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01435837 on ClinicalTrials.gov